Press "Enter" to skip to content

Hoylman hails Pfizer vaccine progress

On Monday, Pfizer shared promising news about the performance of its coronavirus vaccine in recent trials, suggesting it was more than 90 percent effective.

This preliminary result is far above the 60 percent threshold Dr. Anthony Fauci said was the baseline for what he would consider an acceptable vaccine.

State Senator Brad Hoylman is a participant in the Pfizer vaccine trials and also is the author of a bill, S.8182-A/A.10508-A, which authorized licensed pharmacists to administer an approved vaccine for COVID-19.

“I congratulate the researchers and medical personnel who helped achieve this historic milestone, including those at the Vaccine Center at N.Y.U. Langone Health, who have taken such good care of me and other trial participants,” Hoylman said.

“It’s humbling to be a participant in this vaccine trial and do my part to advance a vaccine against a pandemic that has killed more than 1.26 million people worldwide, as well as stand up for science as a public official who believes in the safety and efficacy of vaccines.

“While we should be heartened by this development, we can’t let our guard down,” the state senator warned. “COVID rates are rising in New York and across the country again at a terrifying rate. No vaccine will be ready for distribution this fall and winter, and we all need to take even more precautions to avoid the devastation we lived through in March and April. Now is not the time to let up on social distancing. If anything, a vaccine on the horizon is more incentive to take precautions until a vaccine is safe to distribute.”

In August, Hoylman began participating in a phase-three clinical trial for a vaccine candidate to prevent COVID-19 through the N.Y.U. Grossman School of Medicine, under the auspices of N.Y.U. Langone Health’s Vaccine Center. N.Y.U. Langone Health’s Vaccine Center will be conducting several COVID-19 vaccine trials in conjunction with the national COVID-19 Prevention Network.

Hoylman was just reelected to the Senate and is now running for Manhattan borough president. He received a total of two vaccine shots and will now be monitored for the next two years.

For his part, President Trump has accused the Federal Drug Administration and Democrats of stalling the vaccine process, so as not give him a “Vaccine WIN” before the presidential election.

Governor Cuomo, meanwhile, is urging that the life-saving vaccine not be distributed until Trump is out of office, arguing that it would not be done properly under the current administration.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Mission News Theme by Compete Themes.